Internal Medicine Alert – August 30, 2006
August 30, 2006
View Issues
-
Motion and Mortality
Total energy expenditure was measured using the doubly labeled water technique over a 2-week period. Resting metabolic rate was calculated using indirect calorimetry -
Sore Points on Treating Sore Throats
Clinicians seem not to follow any of several recommended guidelines when evaluating and treating pharyngitis and, as a result, there is widespread over-treatment with antibiotics. -
Finally an Optimal Strategy for Diagnosing Deep Vein Thrombosis
A medical research unit in the United Kingdom analyzed 18 different strategies for managing patients with suspected deep vein thrombosis (DVT). Using systematic review, meta-analysis and cost effectiveness analysis, they settled on an algorithm based on clinical risk. -
PPI or Testing for Helicobacter pylori as the First Step for Patients Presenting with Dyspepsia?
Testing and treating H. pylori and empirical PPI treatment similarly relieved symptoms in dyspeptic patients, but the 'test and treat' strategy resulted in lower endoscopic workload and decreased cost. -
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil°)
The FDA has licensed the first vaccine to prevent cancer due to human papillomaviruses (HPV) types 6, 11, 16, and 18, the most common subtypes of this prevalent virus. -
Clinical Briefs By Louis Kuritzky, MD
Male pattern baldness is a result of the impact of dihydrotestosterone (DHT) upon scalp hair follicles which results in a progressive miniaturization of follicles leading to thinner, shorter hairs in genetically susceptible men.